Holistic care in the management of asymptomatic follicular lymphoma
Optimism for the use of liquid biopsies in multiple myeloma
Andrew Spencer et al.
Results and rational behind breakthrough therapy-designated E-selectin antagonist for AML
Developments in multiple myeloma - immunotherapy and personalized medicine
Lymphoma: chemotherapy vs. bendamustine